Africa’s growing vaccine capacity
Manufacturing products locally for more equitable pandemic responses
While the global vaccination effort to curb the spread of COVID-19 continues to ramp up worldwide, access to COVID-19 vaccines, particularly in low- and middle-income countries, remains staggeringly low. In fact, low- and middle-income countries received less than one percent of available doses.
I think girls everywhere would like to see the day when we do not talk about great women scientists but just great scientists. Being a woman shouldn’t make your achievements any more or less impressive ~ Serena Piervincenzi
Patrick Lukulay, USP’s VP of GHIP–Africa, discusses plans to leverage his new post in Accra, Ghana to advance pharmaceutical quality in Africa. Countering fallacies in drug quality through advocacy and working to help build an enabling environment that can sustain systems for effective regulation of medical products, he says, are needed for this to happen.
Kenya’s National Quality Control Laboratory (NQCL) recently attained a top international accreditation, multi-million dollar laboratory equipment for testing the quality of medicines, a new laboratory information management system, and an upgraded website.
USP staff had the opportunity to hear an animated and truly captivating presentation by Dr. Ian Crozier, an infectious disease physician who was infected with Ebola while treating patients during the Ebola outbreak in West Africa last year.
Poor quality medicines are the source of an alarming, but often overlooked global health crisis. A report from the International Policy Network estimates that 700,000 people die every year from fake anti-malarial and tuberculosis drugs alone.